Earnings History Data for Entasis Therapeutics (ETTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Entasis Therapeutics
Entasis Therapeutics Holdings Inc. produces, researches and develops antibacterial therapies and drugs through its subsidiaries. The company's product pipeline consists of etx2514sul, zoliflodacin, etx0282cpdp and nbp program which are in clinical stage. Entasis Therapeutics Holdings, Inc. is based in Waltham, Massachusetts.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
27-04-2022 | PM | 7:30 AM ET (Apr 27) |
ETTX | Entasis Therapeutics | 90.00 | -0.32 | -0.20 | 0.00 | 1.86 | -0.03 (-1.59%) |
0.0 | 0.0 (0.00%) |
1.40 - 3.88 | 145,488 | 50,000 | 0 | ||
03-03-2022 | PM | 7:30 AM ET (Mar 3) |
ETTX | Entasis Therapeutics | 83.00 | -0.25 | -0.26 | 0.00 | 1.73 | -0.02 (-1.14%) |
1.78 | 0.03 (1.71%) |
1.40 - 3.88 | 20,122 | 100,000 | 700 | ||
04-11-2021 | PM | 8:00 AM ET (Nov 4) |
ETTX | Entasis Therapeutics Holdings Inc. | 139.09 | -0.26 | -0.26 | -0.37 | Entasis Therapeutics EPS beats by $0.02 [11/4/2021 7:45 AM] |
3.09 | 0.04 (1.31%) |
3.07 | 0.02 (0.66%) |
1.64 - 3.88 | 311,252 | 340,000 | 3,130 | |
11-08-2021 | PM | 8:00 AM ET (Aug 12) |
ETTX | Entasis Therapeutics Holdings Inc. | 112.60 | -0.29 | -0.24 | -0.78 | Entasis Therapeutics EPS beats by $0.04 [8/12/2021 1:51 AM] |
2.57 | -0.06 (-2.28%) |
2.63 | 0.0 (0.00%) |
1.58 - 3.74 | 91,933 | 90,000 | 7,935 | |
05-05-2021 | AH | After the close (May 5) |
ETTX | Entasis Therapeutics Holdings Inc. | 79.00 | -0.29 | -0.34 | 0.00 | Entasis Therapeutics EPS beats by $0.07 [5/5/2021 5:03 PM] |
1.82 | -0.05 (-2.67%) |
1.90 | 0.03 (1.60%) |
1.58 - 4.25 | 339,589 | 590,000 | 1,701 | |
23-03-2021 | PM | ETTX | Entasis Therapeutics Holdings Inc. | 100.00 | -0.12 | -0.37 | 0.00 | Entasis Therapeutics EPS beats by $0.30 [3/23/2021 9:42 AM] |
2.43 | -0.28 (-10.33%) |
2.73 | 0.02 (0.74%) |
1.58 - 4.25 | 449,549 | 200,000 | 5,258 | ||